BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9793761)

  • 1. Insulin-like growth factor-I resistance.
    Jain S; Golde DW; Bailey R; Geffner ME
    Endocr Rev; 1998 Oct; 19(5):625-46. PubMed ID: 9793761
    [No Abstract]   [Full Text] [Related]  

  • 2. Insulin-like growth factors and skeletal growth: possibilities for therapeutic interventions.
    Van Wyk JJ; Smith EP
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4349-54. PubMed ID: 10599687
    [No Abstract]   [Full Text] [Related]  

  • 3. [Insulin-like growth factors (IGF) and their binding proteins (IGFBP). Physiological and pathological regulation].
    Le Bouc Y
    Journ Annu Diabetol Hotel Dieu; 1995; ():29-38. PubMed ID: 7541484
    [No Abstract]   [Full Text] [Related]  

  • 4. Insulin-like growth factors.
    LeRoith D; McGuinness M; Shemer J; Stannard B; Lanau F; Faria TN; Kato H; Werner H; Adamo M; Roberts CT
    Biol Signals; 1992; 1(4):173-81. PubMed ID: 1307923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms underlying insulin-like growth factor action: How mutations in the GH: IGF axis lead to short stature.
    Forbes BE
    Pediatr Endocrinol Rev; 2011 Jun; 8(4):374-81. PubMed ID: 21972777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin like growth factors and their importance in pediatrics.
    Philipps AF
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1996; 37(1):1-10. PubMed ID: 8936003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factors I and II are autocrine factors in stimulating proteoglycan synthesis, a marker of differentiated chondrocytes, acting through their respective receptors on a clonal human chondrosarcoma-derived chondrocyte cell line, HCS-2/8.
    Takigawa M; Okawa T; Pan H; Aoki C; Takahashi K; Zue J; Suzuki F; Kinoshita A
    Endocrinology; 1997 Oct; 138(10):4390-400. PubMed ID: 9322955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor receptors. Implications for nervous system function.
    LeRoith D; Werner H; Faria TN; Kato H; Adamo M; Roberts CT
    Ann N Y Acad Sci; 1993 Aug; 692():22-32. PubMed ID: 7692787
    [No Abstract]   [Full Text] [Related]  

  • 9. Insulin-like growth factors and their binding proteins: biological actions.
    Jones JI; Clemmons DR
    Endocr Rev; 1995 Feb; 16(1):3-34. PubMed ID: 7758431
    [No Abstract]   [Full Text] [Related]  

  • 10. [Insulin-like growth factor II (IGF-II)--regulator peptide from the insulin superfamily].
    Kolychev AP
    Zh Evol Biokhim Fiziol; 2000; 36(2):69-82. PubMed ID: 10925843
    [No Abstract]   [Full Text] [Related]  

  • 11. IGF-II is up-regulated and myofibres are hypertrophied in regenerating soleus of mice lacking FGF6.
    Armand AS; Lécolle S; Launay T; Pariset C; Fiore F; Della Gaspera B; Birnbaum D; Chanoine C; Charbonnier F
    Exp Cell Res; 2004 Jul; 297(1):27-38. PubMed ID: 15194422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells.
    Ellis MJ; Leav BA; Yang Z; Rasmussen A; Pearce A; Zweibel JA; Lippman ME; Cullen KJ
    Mol Endocrinol; 1996 Mar; 10(3):286-97. PubMed ID: 8833657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factors: polypeptides with diverse physiological roles.
    Rechler MM
    Mead Johnson Symp Perinat Dev Med; 1988; (32):12-20. PubMed ID: 2485435
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiomyoblast apoptosis induced by insulin-like growth factor (IGF)-I resistance is IGF-II dependent and synergistically enhanced by angiotensin II.
    Kuo WW; Liu CJ; Chen LM; Wu CH; Chu CH; Liu JY; Lu MC; Lin JA; Lee SD; Huang CY
    Apoptosis; 2006 Jul; 11(7):1075-89. PubMed ID: 16699953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-gamma-mediated extravillous trophoblast outgrowth inhibition in first trimester explant culture: a role for insulin-like growth factors.
    Hu Y; Tan R; MacCalman CD; Eastabrook G; Park SH; Dutz JP; von Dadelszen P
    Mol Hum Reprod; 2008 May; 14(5):281-9. PubMed ID: 18430759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense IGF and antisense IGF-IR therapy of malignancy.
    Wang H; Liu Y; Wei L; Guo Y
    Adv Exp Med Biol; 2000; 465():265-72. PubMed ID: 10810632
    [No Abstract]   [Full Text] [Related]  

  • 17. Insulin-like growth factors and diabetes.
    Bach LA; Rechler MM
    Diabetes Metab Rev; 1992 Oct; 8(3):229-57. PubMed ID: 1292913
    [No Abstract]   [Full Text] [Related]  

  • 18. Genetics, chemistry, and function of the IGF/IGFBP system.
    Collett-Solberg PF; Cohen P
    Endocrine; 2000 Apr; 12(2):121-36. PubMed ID: 10905372
    [No Abstract]   [Full Text] [Related]  

  • 19. Alternate signaling pathways selectively regulate binding of insulin-like growth factor I and II on fetal rat bone cells.
    McCarthy TL; Ji C; Casinghino S; Centrella M
    J Cell Biochem; 1998 Mar; 68(4):446-56. PubMed ID: 9493908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.
    Reeve JG; Morgan J; Schwander J; Bleehen NM
    Cancer Res; 1993 Oct; 53(19):4680-5. PubMed ID: 7691401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.